Migraine is a neurovascular disorder characterized by recurrent episodic headaches, and is caused by abnormal processing of sensory information due to peripheral and/or central sensitization. The exact pathophysiological mechanism underlying migraine is not fully understood; however, cortical spreading depression (CSD) is thought to provide the basis for migraine aura and may serve as a trigger of migraine pain. CSD depends on neuronal-glial cell communication, which is mediated by intercellular transfer of messengers through connexin-containing gap junctions, as well as messengers released into the extracellular space by non-junctional connexin-containing hemichannels. These processes are believed to be important in peripheral sensitization within the trigeminal ganglion and to lead to central sensitization. The novel benzopyran compound tonabersat binds selectively to a unique site in the brain. In preclinical studies, tonabersat markedly reduced CSD and CSD-associated events and inhibited gap-junction communication between neurons and satellite glial cells in the trigeminal ganglion. Together, these findings suggest that tonabersat should have clinical application in preventing migraine attacks. © 2009 Blackwell Publishing Ltd.
CITATION STYLE
Durham, P. L., & Garrett, F. G. (2009). Neurological mechanisms of migraine: Potential of the gap-junction modulator tonabersat in prevention of migraine. Cephalalgia, 29(SUPPL. 2), 1–6. https://doi.org/10.1111/j.1468-2982.2009.01976.x
Mendeley helps you to discover research relevant for your work.